Zealand Pharma A/S (ZEAL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Zealand Pharma A/S

    NASDAQ: ZEAL · Real-Time Price · USD
    17.59
    0.00 (0.00%)
    At close: Sep 29, 2022, 10:00 PM

    Zealand Pharma A/S Income Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2022 Q3 2021 Q4 2021 Q2 2021 Q1 2021
    Period Ending Mar 10, 2022 Sep 30, 2021 Sep 6, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 259.82M 292.57M 249.52M 252.03M 388.72M
    Cost of Revenue
    		 97.98M 118.81M 118.41M 128.84M 114.31M
    Gross Profit
    		 161.84M 173.75M 131.11M 123.19M 274.41M
    Operating Income
    		 -1.09B -1.05B -1.18B -1.11B -876.06M
    Interest Income
    		 n/a n/a -370K 3.7M 5.88M
    Pretax Income
    		 -954.84M -1.03B -1.2B -1.15B -900.36M
    Net Income
    		 -957M -1.02B -1.2B -1.15B -909.49M
    Selling & General & Admin
    		 571.91M 636.25M 692.46M 674.14M 612.46M
    Research & Development
    		 605.68M 588.45M 620.25M 597.39M 574.74M
    Other Expenses
    		 -1.03M -759K -256K 321K -331K
    Operating Expenses
    		 1.18B 1.22B 1.31B 1.27B 1.19B
    Interest Expense
    		 20.16M 4.07M 4.21M 6.61M 7.46M
    Selling & Marketing Expenses
    		 327.88M 375.27M 409.42M 413.27M 367.19M
    Cost & Expenses
    		 1.27B 1.34B 1.43B 1.4B 1.3B
    Income Tax Expense
    		 2.16M -8.79M -3.18M 3.01M 9.13M
    Shares Outstanding (Basic)
    		 43.63M 43.15M 43.15M 43.2M 42.15M
    Shares Outstanding (Diluted)
    		 43.63M 43.15M 43.15M 43.2M 42.15M
    EPS (Basic)
    		 -22.12 -23.72 -28.14 -27.41 -22.11
    EPS (Diluted)
    		 -22.12 -23.72 -28.14 -27.41 -22.11
    EBITDA
    		 -976.49M -1.02B -1.18B -1.1B -856.37M
    EBIT
    		 -934.68M -1.02B -1.2B -1.14B -892.89M
    Depreciation & Amortization
    		 116.98M 29.5M 28.08M 45.83M 55.23M

    Add to Watchlist